Switch to
More onapp

How to use scorecard? Learn more

Solara Active Pharma Sciences Ltd

SOLARA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,885 cr, stock is ranked 928
High RiskStock is 4.01x as volatile as Nifty
515.7516.10 (-3.03%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,885 cr, stock is ranked 928
High RiskStock is 4.01x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-11.42
PB RatioPB Ratio
3.08
Dividend YieldDiv. Yield
Sector PESector PE
50.00
Sector PBSector PB
6.36
Sector Div YldSctr Div Yld
0.54%

Forecast & RatingsDetailed Forecast 

0%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation

Financial TrendFinancial statements 

20212022202320241.651.291.471.290.22-0.06-0.02-0.57
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Monitoring Agency Report 
Announced OnFeb 10, 2025

Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted | Download

Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted | Download

Company Update 
Announced OnFeb 10, 2025

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | Download

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 3

See all events